Inograf capsule 0.5 mg 3×10’s

 1,030.00

Manufactured by:
Active Pharmaceutical Ingredient:
Drug Strength: 0.5 mg
Drug Form : Capsule
Pack Size : 3x10’s
Rs. 34 per Capsule
30 Capsule per pack
10 Capsule in each strip
Rs.344 per strip

Inograf capsule contains Tacrolimus, Oral | belongs to Immunomodulator

SKU: pg_11369_15739 Category:

Alternate brands of Inograf capsule 0.5 mg 3×10’s

Brand Name Price Savings
Tacrosan capsule 1 mg 50’s  6,709.00 You will pay -5679 more
Tacrosan capsule 0.5 mg 50’s  4,075.00 You will pay -3045 more
Tacrosan capsule 1 mg 30’s  6,709.59 You will pay -5679.59 more
Tacrosan capsule 0.5 mg 30’s  4,075.46 You will pay -3045.46 more
Tacrobell capsule 1 mg 50’s  6,500.00 You will pay -5470 more
List of alternate brands

Reviews

There are no reviews yet.

Be the first to review “Inograf capsule 0.5 mg 3×10’s”

How it works

Inograf capsule 0.5 mg 3×10’s works by weakening your body's defense system (immune system) to help your body accept the new organ as if it were your own.

Side effects

Major & minor side effects for Inograf capsule 0.5 mg 3×10’s

  • Abdominal pain severe
  • Diarrhea severe
  • Dizziness severe
  • Headache severe
  • Swelling of feet or lower legs severe
  • Blurred vision severe
  • Sweating severe
  • Weight loss severe
  • Loss of strength
  • Body pain
  • Scaly skin

Uses of Inograf capsule 0.5 mg 3×10’s

What is it prescribed for?

  • Organ Transplant - Rejection Prophylaxis

    This medicine is used to prevent organ rejection by reducing the immune response of the body in organ transplant patients.

Concerns

Frequently asked questions

  • Onset of action

    The amount of time required for this medicine to show its action is not clinically established.

  • Duration of Effect

    The amount of time for which this medicine remains active in the body is not clinically established.

  • Safe with Alchohol?

    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

  • Is it habit forming?

    No habit forming tendencies were reported.

  • Usage in pregnancy?

    This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before taking/receiving this medicine.

  • Usage while breast-feeding?

    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. The risks and benefits should be discussed with the doctor before taking/receiving this medicine.

When not to use?

  • Allergy

    This medicine is not recommended for use in patients with a known allergy to Inograf capsule 0.5 mg 3×10’s , or any other inactive ingredients present in the formulation.

Warnings

Warnings for special population
  • Pregnancy

    This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before taking/receiving this medicine.

  • Breast-feeding

    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. The risks and benefits should be discussed with the doctor before taking/receiving this medicine.

General Warnings
  • Lymphoma and Malignancies

    This medicine may increase the risk of developing lymphoma and other malignancies in some patients, especially of the skin. Doctors should inform patients about these risks and advise the patient to prevent exposure of the sunlight by wearing protective clothing.

  • Serious infections

    Use of this medicine may weaken the immune system and may make you more vulnerable to infections. The chance of developing infections (viral, bacterial, fungal, including opportunistic infections) are more during treatment with this medicine. Hold the treatment and start with the broad-spectrum antibiotics if there are any signs and symptoms of fever. Close monitoring of the body temperature and the blood cell count is necessary. It is advised that you avoid coming in contact with people suffering from an infection while receiving this medicine.

  • Liver impairment

    This medicine should be used with extreme caution in patients suffering from moderate or severe liver diseases due to the increased risk of worsening of the patient's condition. Close monitoring of liver function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

  • Kidney impairment

    This medicine should be used with extreme caution in patients suffering from kidney diseases due to the increased risk of worsening of the patient's condition. Close monitoring of kidney function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

  • Hypertension

    This medicine should be used with extreme caution in patients suffering from elevated blood pressure due to the increased risk of worsening of the patient's condition. Close monitoring of blood pressure levels is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

  • Hyperkalemia

    This medicine may increase the levels of potassium in the body and may increase the risk of arrhythmia. Close monitoring of potassium levels is necessary while receiving this medicine. Medicines that can increase the potassium levels like ACE inhibitors and potassium-sparing diuretics should be avoided. Appropriate corrective measures, dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.This medicine may increase the levels of potassium in the body and may increase the risk of arrhythmia. Close monitoring of potassium levels is necessary while receiving this medicine. Medicines that can increase the potassium levels like ACE inhibitors and potassium-sparing diuretics should be avoided. Appropriate corrective measures, dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

  • Driving or operating machinery

    Use of this medicine may cause dizziness, tiredness, visual disturbances, etc. in some patients. Hence, it is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating heavy machinery if you experience any of these symptoms during treatment with this medicine.

  • QT interval prolongation

    This medicine should be used with extreme caution in patients who have or may develop prolongation of QT interval due to the increased risk of worsening of the patient's condition. Close monitoring of the clinical condition, appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Dosage

  • Missed Dose

    The missed dose should be taken as soon as possible. It is advisable to skip the missed dose if it's already time for your next scheduled dose.

  • Overdose

    Seek emergency medical treatment or contact your doctor in case of an overdose.

Interactions

Interaction with Medicines
  • Amlodipine moderate
  • Carbamazepine severe
  • Live attenuated vaccines and related products severe
  • Neomycin severe
  • Piroxicam severe
  • Cyclosporine severe
Disease interactions
  • severe

    This medicine may cause a condition called post-transplant insulin-dependent diabetes mellitus. Insulin should be administered in these patients. Temporary insulin therapy has been required in some patients, while long-term insulin use has been necessary for others. Close monitoring of glucose levels is necessary. This medicine should be administered with caution in patients with pre-transplant diabetes mellitus.

Food interactions
  • Consumption of grapefruit and grapefruit juice is not recommended while taking this medicine due to the risk of serious side effects.

General Instructions

Take this medicine with or without food, as directed by the doctor. Do not take in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.

Other details

  • Can be taken with or without food, as advised by your doctor
  • To be taken as instructed by doctor
  • May cause sleepiness

References

Additional Information>

what are the adverse effects of Inograf capsule 0.5 mg 3×10’s?

Gastro-intestinal disturbances including dyspepsia and inflammatory and ulcerative disorders; hepatic dysfunction, jaundice, bile-duct and gallbladder abnormalities; hypertension (less frequently hypotension), tachycardia, angina, arrhythmias, thromboembolic and ischaemic events, rarely myocardial hypertrophy, cardiomyopathy; dyspnoea, pleural effusion; tremor, headache, insomnia, paraesthesia, confusion, depression, dizziness, anxiety, convulsions, incoordination, encephalopathy, psychosis; visual and hearing abnormalities; haematological effects including anaemia, leukocytosis, leucopenia, thrombocytopenia, Coagulation disorders; altered acid-base balance and glucose metabolism, electrolyte disturbances including hyperkalaemia (less frequently hypokalaemia); altered renal function including increased serum creatinine; hypophosphataemia, hypercalcaemia, hyperuricaemia; muscle cramps, arthralgia; pruritus, alopecia, rash, sweating, acne, photosensitivity; susceptibility to lymphoma and other malignancies particularly of the skin; less commonly ascites, pancreatitis, atelectasis, kidney damage and renal failure, myasthaenia, hirsutism; rarely Stevens-Johnson syndrome.

What happens if I miss a dose of Inograf capsule 0.5 mg 3×10’s?

Primary immunosuppression in liver & kidney allograft recipients: Adults: Oral liver transplantation: 0.1-0.2 mg/Kg/day in 2 divided doses, start approx 6 hr after completion of surgery.
Kidney transplantation: 0.15-0.3 mg/Kg/day in 2 divided doses, start within 24 hr of surgery.
Children: Oral liver transplantation: 0.3 mg/kg/day in 2 divided doses.
Allograft rejection resistant to conventional immunosuppressive regimens: Begin with initial dose for primary immunosuppression in that particular allograft.

One of the following licensed pharmacy from the nearest location will deliver Inograf capsule 0.5 mg 3×10’s. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.

Questions and Answers

There are no questions yet. Be the first to ask a question about this product.

Only registered users are eligible to enter questions

Shopping Cart

Medicalstore.com.pk © All rights reserved

Made with ❤ by Dairah